An oncogenic tyrosine kinase inhibits DNA repair and DNA-damage-induced Bcl-xL deamidation in T cell transformation

Cancer Cell

Volumn 5, Issue 1, 2004, Pages 37-49

  Zhao, Rui ^a   Yang, Feng Tang ^b   Alexander, Denis R ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; PROTEIN BCL XL; PROTEIN TYROSINE KINASE;

ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; DEAMINATION; DNA DAMAGE; DNA REPAIR; ENZYME ACTIVITY; GENE TRANSLOCATION; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; T CELL LYMPHOMA; T LYMPHOCYTE; THYMOCYTE; TRANSGENIC MOUSE; UPREGULATION;

ANIMALIA; MUS MUSCULUS;

EID: 1642430927     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(03)00333-7     Document Type: Article

References (60)

1. Abraham K.M., Levin S.D., Marth J.D., Forbush K.A., Perlmutter R.M. Thymic tumorigenesis induced by overexpression of P56lck. Proc. Natl. Acad. Sci. USA. 88:1991;3977-3981.
2. Alexander D.R. The role of the CD45 phosphotyrosine phosphatase in lymphocyte signalling. Subversion and Manipulation M.M., Harnett and K.P., Rigley Lymphocyte Signalling. Mechanisms:1997;107-140 John Wiley & Sons Ltd, Sussex, England.
3. Alexander D.R. The CD45 tyrosine phosphatase. a positive and negative regulator of immune cell function Semin. Immunol. 12:2000;349-359.
4. Amarante-Mendes G.P., McGahon A.J., Nishioka W.K., Afar D.E., Witte O.N., Green D.R. Bcl-2-independent BCR-ABL-mediated resistance to apoptosis. protection is correlated with up regulation of Bcl-xL Oncogene. 16:1998;1383-1390.
5. Amundson S.A., Myers T.G., Scudiero D., Kitada S., Reed J.C., Fornace A.J. An informatics approach identifying markers of chemosensitivity in human cancer cell lines. Cancer Res. 60:2000;6101-6110.
6. Anderson S.J., Levin S.D., Perlmutter R.M. Protein-tyrosine kinase p56(Lck) controls allelic exclusion of T-cell receptor beta-chain genes. Nature. 365:1993;552-554.
7. L. J. Biol. Chem. 272:1997;27886-27892.
8. Aswad D.W., Paranandi M.V., Schurter B.T. Isoaspartate in peptides and proteins. formation, significance, and analysis J. Pharm. Biomed. Anal. 21:2000;1129-1136.
9. Baker M., Gamble J., Tooze R., Higgins D., Yang F.T., O'Brien P.C.M., Coleman N., Pingel S., Turner M., Alexander D.R. Development of T-leukaemias in CD45 tyrosine phosphatase-deficient mutant lck mice. EMBO J. 19:2000;4644-4654.
10. Bassing C.H., Swat W., Alt F.W. The mechanism and regulation of chromosomal V(D)J recombination. Cell. 109(Suppl):2002;S45-S55.
11. Bassing C.H., Suh H., Ferguson D.O., Chua K.F., Manis J., Eckersdorff M., Gleason M., Bronson R., Lee C., Alt F.W. Histone H2AX. A dosage-dependent suppressor of oncogenic translocations and tumors Cell. 114:2003;359-370.
12. Bullock A.N., Fersht A.R. Rescuing the function of mutant p53. Nat. Rev. Cancer. 1:2001;68-76.
13. Byth K.F., Conroy L.A., Howlett S., Smith A.J.H., May J., Alexander D.R., Holmes N. CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4(+)CD8(+) thymocytes, and in B-cell maturation. J. Exp. Med. 183:1996;1707-1718.
14. Cheng E.H., Wei M.C., Weiler S., Flavell R.A., Mak T.W., Lindsten T., Korsmeyer S.J. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell. 8:2001;705-711.
15. Cohen G.M., Sun X.M., Fearnhead H., MacFarlane M., Brown D.G., Snowden R.T., Dinsdale D. Formation of large molecular weight fragments of DNA is a key committed step of apoptosis in thymocytes. J. Immunol. 153:1994;507-516.
16. De Silva I.U., McHugh P.J., Clingen P.H., Hartley J.A. Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. Mol. Cell. Biol. 20:2000;7980-7990.
17. Deutsch E., Dugray A., AbdulKarim B., Marangoni E., Maggiorella L., Vaganay S., M'Kacher R., Rasy S.D., Eschwege F., Vainchenker W.et al. BCR-ABL down-regulates the DNA repair protein DNA-PKcs. Blood. 97:2001;2084-2090.
18. Deverman B.E., Cook B.L., Manson S.R., Niederhoff R.A., Langer E.M., Rosova I., Kulans L.A., Fu X., Weinberg J.S., Heinecke J.W.et al. Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage. Cell. 111:2002;51-62.
19. L deamidation is a critical switch in the regulation of the response to DNA damage Cell. 115:2003;503.
20. Falk I., Nerz G., Haidl I., Krotkova A., Eichmann K. Immature thymocytes that fail to express TCRbeta and/or TCRgamma delta proteins die by apoptotic cell death in the CD44(-)CD25(-) (DN4) subset. Eur. J. Immunol. 31:2001;3308-3317.
21. Ferguson-Smith M.A. Genetic analysis by chromosome sorting and painting. phylogenetic and diagnostic applications Eur. J. Hum. Genet. 5:1997;253-265.
22. Gross A., Jockel J., Wei M.C., Korsmeyer S.J. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17:1998;3878-3885.
23. Haks M.C., Krimpenfort P., van den Brakel J.H.N., Kruisbeek A.M. Pre-TCR signalling and inactivation of p53 induces crucial cell survival pathways in pre-T cells. Immunity. 11:1999;91-101.
24. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70.
25. Hengartner M.O. The biochemistry of apoptosis. Nature. 407:2000;770-776.
26. Holdorf A.D., Lee K.H., Burack W.R., Allen P.M., Shaw A.S. Regulation of Lck activity by CD4 and CD28 in the immunological synapse. Nat. Immunol. 3:2002;259-264.
27. Hsu Y.T., Youle R.J. Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. J. Biol. Chem. 273:1998;10777-10783.
28. Huang D.C., Strasser A. BH3-Only proteins-essential initiators of apoptotic cell death. Cell. 103:2000;839-842.
29. Jain S.K., Susa M., Keeler M.L., Carlesso N., Druker B., Varticovski L. PI 3-kinase activation in BCR/abl-transformed hematopoietic cells does not require interaction of p85 SH2 domains with p210 BCR/abl. Blood. 88:1996;1542-1550.
30. Khanna K.K., Jackson S.P. DNA double-strand breaks. signaling, repair and the cancer connection Nat. Genet. 27:2001;247-254.
31. Kumar R., Mandal M., Lipton A., Harvey H., Thompson C.B. Overexpression of Her2 modulates Bcl-2, Bcl-X(L), and tamoxifen-induced apoptosis in human Mcf-7 breast-cancer cells. Clin. Cancer Res. 2:1996;1215-1219.
32. Kuwana T., Mackey M.R., Perkins G., Ellisman M.H., Latterich M., Schneiter R., Green D.R., Newmeyer D.D. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell. 111:2002;331-342.
33. Letai A., Bassik M.C., Walensky L.D., Sorcinelli M.D., Weiler S., Korsmeyer S.J. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell. 2:2002;183-192.
34. Lin K., Longo N.S., Wang X., Hewitt J.A., Abraham K.M. Lck domains differentially contribute to pre-T cell receptor (TCR)- and TCR-alpha/beta- regulated developmental transitions. J. Exp. Med. 191:2000;703-716.
35. Ma A., Pena J.C., Chang B., Margosian E., Davidson L., Alt F.W., Thompson C.B. Bclx regulates the survival of double-positive thymocytes. Proc. Natl. Acad. Sci. USA. 92:1995;4763-4767.
36. Marani M., Tenev T., Hancock D., Downward J., Lemoine N.R. Identification of novel isoforms of the BH3 domain protein Bim which directly activate Bax to trigger apoptosis. Mol. Cell. Biol. 22:2002;3577-3589.
37. Nechushtan A., Smith C.L., Hsu Y.T., Youle R.J. Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBO J. 18:1999;2330-2341.
38. O'Connor L., Strasser A., O'Reilly L.A., Hausmann G., Adams J.M., Cory S., Huang D.C. Bim. a novel member of the Bcl-2 family that promotes apoptosis EMBO J. 17:1998;384-395.
39. Pingel S., Baker M., Turner M., Holmes N., Alexander D.R. The CD45 tyrosine phosphatase regulates CD3-induced signal transduction and T cell development in recombinase-deficient mice. restoration of pre-TCR function by active p56(lck) Eur. J. Immunol. 29:1999;2376-2384.
40. Richardson C., Jasin M. Frequent chromosomal translocations induced by DNA double-strand breaks. Nature. 405:2000;697-700.
41. Robinson N.E., Robinson A.B. Molecular clocks. Proc. Natl. Acad. Sci. USA. 98:2001;944-949.
42. Rodewald H.R., Fehling H.J. Molecular and cellular events in early thymocyte development. Adv. Immunol. 69:1998;1-112.
43. Rodriguez J., Lazebnik Y. Caspase-9 and APAF-1 form an active holoenzyme. Genes Dev. 13:1999;3179-3184.
44. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M. DNA double-stranded breaks induce H2AX phosphorylation on serine 139. J. Biol. Chem. 273:1998;5858-5868.
45. Salomoni P., Condorelli F., Sweeney S.M., Calabretta B. Versatility of BCR/ABL-expressing leukemic cells in circumventing proapoptotic BAD effects. Blood. 96:2000;676-684.
46. Sherr C.J., McCormick F. The RB and p53 pathways in cancer. Cancer Cell. 2:2002;103-112.
47. Siliciano J.D., Canman C.E., Taya Y., Sakaguchi K., Appella E., Kastan M.B. DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev. 11:1997;3471-3481.
48. Simbulan-Rosenthal C.M., Rosenthal D.S., Iyer S., Boulares H., Smulson M.E. Involvement of PARP and poly(ADP-ribosyl)ation in the early stages of apoptosis and DNA replication. Mol. Cell. Biochem. 193:1999;137-148.
49. Skorski T. Oncogenic tyrosine kinases and the DNA-damage response. Nat. Rev. Cancer. 2:2002;351-360.
50. Slupianek A., Hoser G., Majsterek I., Bronisz A., Malecki M., Blasiak J., Fishel R., Skorski T. Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)/M phase, and protection from apoptosis. Mol. Cell. Biol. 22:2002;4189-4201.
51. Stone J.D., Conroy L.A., Byth K.F., Hederer R.A., Howlett S., Takemoto Y., Holmes N., Alexander D.R. Aberrant TCR-mediated signalling in CD45-null thymocytes involves dysfunctional regulation of Lck, Fyn, TCR-ζ and ZAP-70. J. Immunol. 158:1997;5773-5782.
52. Sun A.Q., Yuksel K.U., Gracy R.W. Terminal marking of triosephosphate isomerase. consequences of deamidation Arch. Biochem. Biophys. 322:1995;361-368.
53. Telenius H., Pelmear A.H., Tunnacliffe A., Carter N.P., Behmel A., Ferguson-Smith M.A., Nordenskjold M., Pfrangner R., Ponder B.A. Cytogenetic analysis by chromosome painting using DOP-PCR amplified flow-sorted chromosomes. Genes Chromosomes Cancer. 4:1992;256-263.
54. Vousden K.H., Lu X. Live or let die. the cell's response to p53 Nat. Rev. Cancer. 2:2002;594-604.
55. Wang Z.H., Ding M.X., Yuan J.P., Jin M.L., Hao C.F., Chew-Cheng S.B., Ng H.K., Chew E.C. Expression of bcl-2 and Bax in EGFR-antisense transfected and untransfected glioblastoma cells. Anticancer Res. 19:1999;4167-4170.
56. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev. 15:2001;2922-2933. a.
57. Wang J.Y., Naderi S., Chen T.T. Role of retinoblastoma tumor suppressor protein in DNA damage response. Acta Oncol. 40:2001;689-695. b.
58. Yang F., Carter N.P., Shi L., Ferguson-Smith M.A. A comparative study of karyotypes of muntjacs by chromosome painting. Chromosoma. 103:1995;642-652.
59. Zlotnik A., Ransom J., Frank G., Fischer M., Howard M. Interleukin 4 is a growth factor for activated thymocytes. possible role in T-cell ontogeny Proc. Natl. Acad. Sci. USA. 84:1987;3856-3860.
60. Zou H., Li Y., Liu X., Wang X. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274:1999;11549-11556.